Paclitaxel is contraindicated in patients who have a history of severe hypersensitivity reactions to paclitaxel or other drugs formulated in Cremophor + EL (polyethoxylated castor oil).
Paclitaxel should not be used in patients with severe baseline neutropenia (<1,500 cells/mm3).